Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Labroots Announces 7th Annual Microbiology Virtual Week Online Event Breaking Barriers to Sharing Scientific Research, scheduled September 7-9, 2021
  • USA - English

The 3-day symposium covering a broad range of topics in Microbiology including, Immunology, Infectious Disease, Respiratory Viruses, Microbial Communities, and Modeling Approaches, promises to be a must-attend event


News provided by

Labroots

Sep 02, 2021, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Microbiology Virtual Week, September 7-9
Microbiology Virtual Week, September 7-9

YORBA LINDA, Calif., Sept. 2, 2021 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is delighted to announce Microbiology Virtual Week, the 7th of its kind held annually to be hosted on September 7-9th. The focus during this free, event remains consistent carrying forward the ongoing tradition of addressing novel technologies, opportunities and challenges, and most relevant, to the future of microbiology in today's world.

Discussed like never before, more than 12,000 attendees will be immersed in cutting-edge sessions by some of the brightest minds in the field to better understand, treat and prevent infectious and immunologic diseases, and engage in basic, clinical and epidemiologic sciences. The comprehensive 3-day agenda will include over 30 presentations from academia and industry prominent speakers, including a handful of stellar keynote deliveries. This prestigious form brings together thousands of research scholars, top scientists, clinicians, healthcare professionals, laboratory technicians, and infectious disease experts all under one virtual roof to get important questions answered by experts who are revolutionizing future research from all facets in the microbiology field.

Microbiology Virtual Week 2021 brings five distinguished keynote speakers to the virtual stage kicking off each day:

  • Ricardo Rajsbaum, PhD, Associate Professor, Department of Microbiology and Immunology University of Texas Medical Branch (UTMB): The Virus, the Host and the Battle for Survival: How Viruses Interact with the Host Ubiquitin Machinery to Promote Susceptibility or Resistance to Infection.
  • Shou-Wei Ding, PhD, Distinguished Professor, Department of Microbiology & Plant Pathology, Institute for Integrative Genome Biology, University of California, Riverside: Mammalian RNAi Response to Virus Infection
  • Matthew Sullivan, PhD, Professor of Microbiology and Civil, Environmental and Geodetic Engineering; Gordon and Betty Moore Foundation Investigator; Co-director OSU Infectious Diseases Institute Microbial Communities Program: Viromics: Lessons from the Oceans, Soils, and Humans
  • Adolfo Garcia-Sastre, PhD, Professor, Departments of Microbiology and Medicine, Tisch Cancer Center Icahn School of Medicine at Mount Sinai: Development of an Affordable COVID-19 Vaccine Based on a Newcastle Disease Virus Platform
  • Daniel Griffin, MD, PhD, Chief, Division of Infectious Disease - ProHEALTH, an OPTUM Company; Senior Fellow for Infectious Disease - UHG Research and Development: COVID-19 Point of Care Diagnostics: The Importance of Timing and RNA Levels

Dr. Ricardo Rajsbaum, Associate Professor, Department of Microbiology and Immunology University of Texas Medical Branch said, "As we continue to experience the effects of the virus causing COVID-19, we see now in real time how the appearance of SARS-CoV-2 variants represent viral evolution, which happens because of the constant interactions that take place between the virus and the host. This also applies to many other pathogenic viruses. By studying other pathogenic viruses, we can learn general mechanisms of viral immune escape. In this lecture, clever ways used by different pathogenic viruses to replicate efficiently by hijacking host antiviral factors will be discussed, and Labroots' platform is a great way to explore these new discoveries."

Dr. Adolfo Garcia-Sastre, Professor, Departments of Microbiology and Medicine at Icahn School of Medicine at Mount Sinai stated, "We are working on an affordable, easy to scale up, COVID-19 vaccine. The vaccine is based on a viral vector commonly used in veterinarian vaccines, Newcastle disease virus, and therefore, easy to manufacture and distribute."

Dr. Daniel Griffin, Chief Division of Infectious Disease, ProHEALTH commented, "Critical in control of this pandemic is the ability to rapidly identify infectious individuals prior to their ability to infect others. While the original testing approaches for COVID-19 diagnosis focused on using PCR, which often had significant delays in getting results, the introduction of tests that use alternative technology such as antigen detection and give results in minutes and may be better at rapidly identifying infectious individuals prior to transmission."

Spanning the 3-day program, presentations will share unique insights from a variety of scientific disciplines highlighting, serological and cellular approaches to COVID-19 research using flow cytometry, identify viroids as infectious non-coding RNAs, from viral infection to neurodegeneration – the role of innate immunity, understand the impact of environmental factors on plant virus-induced disease, understand the emerging RNA viruses, virus replication: the role of the unique pathogenic organelle, explain current approaches to the development of RNA-replicon vaccine candidates against SARS-CoV-2, genetic approaches and host targets to inhibit influenza virus pathogenesis, gut microbiota in maternal-infant populations with HIV, machine learning approaches for modeling complex community dynamics, RNA viruses reshape the RNA modification landscape in the cell, and tracking of novel SARS-CoV-2 lineages through wastewater surveillance, and so much more!

Greg Cruikshank, Chief Executive Officer of Labroots added, "Microbiology Virtual Week, 2021 continues to deliver each year, providing a comprehensive jam-packed program to educate attendees on the latest discoveries, and gather recognized leaders from around the world. We are thrilled to serve as the catalyst to the scientific community through our virtual event offerings, and continuing to advance immunological research and extend the understanding of how to treat significant health issues and disease."

Produced on Labroots' robust platform with the capability to connect across all desktops and mobile devices, the online environment provides a complete one-stop educational experience. Participants will enjoy the lobby, auditorium featuring live-streaming video webcasts (live chat feature enabled during all scheduled presentations), interactive poster hall (explore data and engage in live chat conversations), exhibit hall (interact with sponsors and view the latest array of products and technologies), and a networking lounge offering new engaging ways to connect with colleagues, including a social media wall.
By participating in this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits.

To register for the event, click here. Join the online conversation and use the official event hashtag #LRmicro to stay up to date on the latest information.

About Labroots
Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Media Contact

Lynn Brainard, Labroots, 714-771-4397, [email protected]

Twitter

SOURCE Labroots

Related Links

http://www.labroots.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.